{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:30Z","timestamp":1786985070043,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bcmd.2021.102605","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T22:31:44Z","timestamp":1631658704000},"page":"102605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil"],"prefix":"10.1016","volume":"92","author":[{"given":"Ana Paula","family":"de Azambuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Michels","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Bitencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmem","family":"Bonfim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariester","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.bcmd.2021.102605_bb0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal","volume":"333","author":"Hillmen","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2021.102605_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytometry B Clin. Cytom."},{"issue":"4","key":"10.1016\/j.bcmd.2021.102605_bb0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1309\/AJCPMRDZZFQM7YJ4","article-title":"Use of a FLAER-based WBC assay in the primary screening of PNH clones","volume":"132","author":"Sutherland","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2021.102605_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOH.0b013e328351c348","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"19","author":"Parker","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2021.102605_bb0025","doi-asserted-by":"crossref","unstructured":"1972-Dacie_Lewis_Ser_Haematol__1972_5_3-23.pdf 1972.","DOI":"10.1111\/j.1365-2141.1972.tb03496.x"},{"issue":"4","key":"10.1016\/j.bcmd.2021.102605_bb0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2141.2001.03191.x","article-title":"Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones","volume":"115","author":"Maciejewski","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.bcmd.2021.102605_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cytob.21139","article-title":"A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure","volume":"86","author":"Raza","year":"2014","journal-title":"Cytometry B Clin. Cytom."},{"issue":"5","key":"10.1016\/j.bcmd.2021.102605_bb0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjh.14862","article-title":"The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy","volume":"182","author":"Bat","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102605_bb0045","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00277-020-04052-z","article-title":"Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the international PNH Registry","volume":"99","author":"Schrezenmeier","year":"2020","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102605_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bjhh.2015.01.001","article-title":"Paroxysmal nocturnal hemoglobinuria clone in 103 Brazilian patients: diagnosis and classification","volume":"37","author":"de Azambuja","year":"2015","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"5","key":"10.1016\/j.bcmd.2021.102605_bb0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.16427","article-title":"Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry","volume":"189","author":"Richards","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102605_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2021.102605_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/asheducation-2016.1.208","article-title":"Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"1","author":"Parker","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"8","key":"10.1016\/j.bcmd.2021.102605_bb0070","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Review in translational hematology current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood J."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102605_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0609.2011.01615.x","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia","volume":"87","author":"Pu","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"8","key":"10.1016\/j.bcmd.2021.102605_bb0080","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","article-title":"Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories","volume":"112","author":"De Latour","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcmd.2021.102605_bb0085","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood.V85.5.1371.bloodjournal8551371","article-title":"Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia","volume":"85","author":"Nakakuma","year":"1995","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2021.102605_bb0090","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.3324\/haematol.2016.151852","article-title":"Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients","volume":"102","author":"Urbano-Ispizua","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bcmd.2021.102605_bb0095","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3324\/haematol.2009.017889","article-title":"Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine","volume":"95","author":"Scheinberg","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bcmd.2021.102605_bb0100","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.14790","article-title":"Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia","volume":"178","author":"Narita","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102605_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/cyto.b.21610","article-title":"ICCS\/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 \u2013 reagent selection and assay optimization for high-sensitivity testing","volume":"94","author":"Sutherland","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"issue":"5","key":"10.1016\/j.bcmd.2021.102605_bb0110","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00277-019-03644-8","article-title":"Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study","volume":"98","author":"Gatti","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2021.102605_bb0115","series-title":"Diagnosis and Monitoring of Paroxysmal Nocturnal","author":"Borowitz","year":"2010"},{"key":"10.1016\/j.bcmd.2021.102605_bb0120","series-title":"Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program","article-title":"Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy","author":"Parker","year":"2011"},{"issue":"1","key":"10.1016\/j.bcmd.2021.102605_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5581\/1516-8484.20110012","article-title":"Frequency of paroxysmal nocturnal hemoglobinuria in patients attended in Bel\u00e9m, Par\u00e1, Brazil","volume":"33","author":"Brito","year":"2010","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.bcmd.2021.102605_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-021-01372-0","article-title":"Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study","author":"Debureaux","year":"2021","journal-title":"Bone Marrow Transplant."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:36:08Z","timestamp":1761050168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979621000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"alternative-id":["S1079979621000711"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102605","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102605"}}